Hi Charles89,
I agree with the LFT/ART approach which will promotes results to testing being known quicker as long as there high sensitivity (which EuGeni can deliver).
With regards the 3% of people getting missed, I think it’s important to highlight that figure relates to those who are positive cases. Imo if 10,000 people attend a concert and the prevalence of COVID-19 is 2% or less within that city’s population, you could then assume that 200 people have COVID-19. If everyone is tested we could assume that the “3% of people being missed” would total 6 people out of 10,000. Of those 6 missed, some may not be infectious, all 6 may not be infectious.
I hope the example I’ve given makes sense and has some merit.
aimho
GLTAH
Hi Charles89,I agree with the LFT/ART approach which will...
-
- There are more pages in this discussion • 630 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.36M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $33.18K | 1.658M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 2717347 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 723484 | 6 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| ADO (ASX) Chart |